Similar protective effects of Beclin 1 have also been reported for gastric cancer, intrahepatic cholangiocellular carcinoma, extranodal natural killer T-cell lymphoma, and stage IIIB colon cancer [6–8,12]. This evidence concerns the gene BECN1 and gastric cancer.